Tonix Pharmaceuticals Holding Corp. (TNXP) › Long-Term DebtTonix Pharmaceuticals Holding Corp. (TNXP): Long-Term DebtAnnual figures by period end, from SEC filings.$8.65MAs of 2024-12-31$11.00M2023-12-31: $11.00M2024-12-31: $8.65M$8.65M2023-12-31 Long-Term Debt (USD) 2024-12-31Period endedLong-Term DebtChange YoYSource filing2024-12-31$8.65M-21.4%2026-03-12, Balance as of period end2023-12-31$11.00Mn/a2025-03-18, Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeDepreciation & AmortizationEBITDANet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesShares OutstandingWeighted Average Diluted SharesEPS (Basic)